Logan Charles Ganzen - Publications

Purdue University, West Lafayette, IN, United States 
Zebrafish, visual system, drug discover

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ganzen L, Ko MJ, Zhang M, Xie R, Chen Y, Zhang L, James R, Mumm J, van Rijn RM, Zhong W, Pang CP, Zhang M, Tsujikawa M, Leung YF. Drug screening with zebrafish visual behavior identifies carvedilol as a potential treatment for an autosomal dominant form of retinitis pigmentosa. Scientific Reports. 11: 11432. PMID 34075074 DOI: 10.1038/s41598-021-89482-z  0.603
2019 Ko MJ, Ganzen LC, Coskun E, Mukadam AA, Leung YF, van Rijn RM. A critical evaluation of TRPA1-mediated locomotor behavior in zebrafish as a screening tool for novel anti-nociceptive drug discovery. Scientific Reports. 9: 2430. PMID 30787340 DOI: 10.1038/S41598-019-38852-9  0.558
2019 Ganzen L, Leung YF. The FDA-approved drug Carvedilol improves vison and retinal morphology in a zebrafish model of retinitis pigmentosa Ibro Reports. 6. DOI: 10.1016/J.Ibror.2019.07.1198  0.57
2017 Ganzen L, Venkatraman P, Pang CP, Leung YF, Zhang M. Utilizing Zebrafish Visual Behaviors in Drug Screening for Retinal Degeneration. International Journal of Molecular Sciences. 18. PMID 28574477 DOI: 10.3390/Ijms18061185  0.63
2017 Ganzen L, Pui Pang C, Zhang M, Tsujikawa M, Fai Leung Y. 2217 Journal of Clinical and Translational Science. 1: 3-4. DOI: 10.1017/CTS.2017.30  0.425
Show low-probability matches.